Report Overview
Molecular diagnostics involves the analysis of genetic material (DNA or RNA) to detect specific pathogens, mutations, or genetic markers associated with diseases.
The global Point-of-care Molecular Diagnostic Solution market size was estimated at USD 4200 million in 2023 and is projected to reach USD 9662.93 million by 2032, exhibiting a CAGR of 9.70% during the forecast period.
North America Point-of-care Molecular Diagnostic Solution market size was estimated at USD 1283.95 million in 2023, at a CAGR of 8.31% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Point-of-care Molecular Diagnostic Solution market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Point-of-care Molecular Diagnostic Solution Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Point-of-care Molecular Diagnostic Solution market in any manner.
Global Point-of-care Molecular Diagnostic Solution Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Abbott Laboratories
F. Hoffmann-La Roche AG
Becton
Dickinson and Company
BioMerieux
Bio-Rad Laboratories
Inc.
Cepheid
Inc.
Danaher Corporation
Johnson and Johnson
Bayer Healthcare
Market Segmentation (by Type)
Assays & kits
Instruments & Analyzers
Software & Services
Market Segmentation (by Application)
Physicians
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Point-of-care Molecular Diagnostic Solution
1.2 Key Market Segments
1.2.1 Point-of-care Molecular Diagnostic Solution Segment by Type
1.2.2 Point-of-care Molecular Diagnostic Solution Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Point-of-care Molecular Diagnostic Solution Market Overview
2.1 Global Market Overview
2.1.1 Global Point-of-care Molecular Diagnostic Solution Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Point-of-care Molecular Diagnostic Solution Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Point-of-care Molecular Diagnostic Solution Market Competitive Landscape
3.1 Global Point-of-care Molecular Diagnostic Solution Sales by Manufacturers (2019-2025)
3.2 Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Manufacturers (2019-2025)
3.3 Point-of-care Molecular Diagnostic Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Point-of-care Molecular Diagnostic Solution Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Point-of-care Molecular Diagnostic Solution Sales Sites, Area Served, Product Type
3.6 Point-of-care Molecular Diagnostic Solution Market Competitive Situation and Trends
3.6.1 Point-of-care Molecular Diagnostic Solution Market Concentration Rate
3.6.2 Global 5 and 10 Largest Point-of-care Molecular Diagnostic Solution Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Point-of-care Molecular Diagnostic Solution Industry Chain Analysis
4.1 Point-of-care Molecular Diagnostic Solution Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Point-of-care Molecular Diagnostic Solution Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Point-of-care Molecular Diagnostic Solution Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Type (2019-2025)
6.3 Global Point-of-care Molecular Diagnostic Solution Market Size Market Share by Type (2019-2025)
6.4 Global Point-of-care Molecular Diagnostic Solution Price by Type (2019-2025)
7 Point-of-care Molecular Diagnostic Solution Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Point-of-care Molecular Diagnostic Solution Market Sales by Application (2019-2025)
7.3 Global Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Application (2019-2025)
7.4 Global Point-of-care Molecular Diagnostic Solution Sales Growth Rate by Application (2019-2025)
8 Point-of-care Molecular Diagnostic Solution Market Consumption by Region
8.1 Global Point-of-care Molecular Diagnostic Solution Sales by Region
8.1.1 Global Point-of-care Molecular Diagnostic Solution Sales by Region
8.1.2 Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Region
8.2 North America
8.2.1 North America Point-of-care Molecular Diagnostic Solution Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Point-of-care Molecular Diagnostic Solution Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Point-of-care Molecular Diagnostic Solution Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Point-of-care Molecular Diagnostic Solution Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Point-of-care Molecular Diagnostic Solution Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Point-of-care Molecular Diagnostic Solution Market Production by Region
9.1 Global Production of Point-of-care Molecular Diagnostic Solution by Region (2019-2025)
9.2 Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Region (2019-2025)
9.3 Global Point-of-care Molecular Diagnostic Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Point-of-care Molecular Diagnostic Solution Production
9.4.1 North America Point-of-care Molecular Diagnostic Solution Production Growth Rate (2019-2025)
9.4.2 North America Point-of-care Molecular Diagnostic Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Point-of-care Molecular Diagnostic Solution Production
9.5.1 Europe Point-of-care Molecular Diagnostic Solution Production Growth Rate (2019-2025)
9.5.2 Europe Point-of-care Molecular Diagnostic Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Point-of-care Molecular Diagnostic Solution Production (2019-2025)
9.6.1 Japan Point-of-care Molecular Diagnostic Solution Production Growth Rate (2019-2025)
9.6.2 Japan Point-of-care Molecular Diagnostic Solution Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Point-of-care Molecular Diagnostic Solution Production (2019-2025)
9.7.1 China Point-of-care Molecular Diagnostic Solution Production Growth Rate (2019-2025)
9.7.2 China Point-of-care Molecular Diagnostic Solution Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Abbott Laboratories
10.1.1 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Basic Information
10.1.2 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product Overview
10.1.3 Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product Market Performance
10.1.4 Abbott Laboratories Business Overview
10.1.5 Abbott Laboratories Point-of-care Molecular Diagnostic Solution SWOT Analysis
10.1.6 Abbott Laboratories Recent Developments
10.2 F. Hoffmann-La Roche AG
10.2.1 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Basic Information
10.2.2 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product Overview
10.2.3 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product Market Performance
10.2.4 F. Hoffmann-La Roche AG Business Overview
10.2.5 F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution SWOT Analysis
10.2.6 F. Hoffmann-La Roche AG Recent Developments
10.3 Becton
10.3.1 Becton Point-of-care Molecular Diagnostic Solution Basic Information
10.3.2 Becton Point-of-care Molecular Diagnostic Solution Product Overview
10.3.3 Becton Point-of-care Molecular Diagnostic Solution Product Market Performance
10.3.4 Becton Point-of-care Molecular Diagnostic Solution SWOT Analysis
10.3.5 Becton Business Overview
10.3.6 Becton Recent Developments
10.4 Dickinson and Company
10.4.1 Dickinson and Company Point-of-care Molecular Diagnostic Solution Basic Information
10.4.2 Dickinson and Company Point-of-care Molecular Diagnostic Solution Product Overview
10.4.3 Dickinson and Company Point-of-care Molecular Diagnostic Solution Product Market Performance
10.4.4 Dickinson and Company Business Overview
10.4.5 Dickinson and Company Recent Developments
10.5 BioMerieux
10.5.1 BioMerieux Point-of-care Molecular Diagnostic Solution Basic Information
10.5.2 BioMerieux Point-of-care Molecular Diagnostic Solution Product Overview
10.5.3 BioMerieux Point-of-care Molecular Diagnostic Solution Product Market Performance
10.5.4 BioMerieux Business Overview
10.5.5 BioMerieux Recent Developments
10.6 Bio-Rad Laboratories
10.6.1 Bio-Rad Laboratories Point-of-care Molecular Diagnostic Solution Basic Information
10.6.2 Bio-Rad Laboratories Point-of-care Molecular Diagnostic Solution Product Overview
10.6.3 Bio-Rad Laboratories Point-of-care Molecular Diagnostic Solution Product Market Performance
10.6.4 Bio-Rad Laboratories Business Overview
10.6.5 Bio-Rad Laboratories Recent Developments
10.7 Inc.
10.7.1 Inc. Point-of-care Molecular Diagnostic Solution Basic Information
10.7.2 Inc. Point-of-care Molecular Diagnostic Solution Product Overview
10.7.3 Inc. Point-of-care Molecular Diagnostic Solution Product Market Performance
10.7.4 Inc. Business Overview
10.7.5 Inc. Recent Developments
10.8 Cepheid
10.8.1 Cepheid Point-of-care Molecular Diagnostic Solution Basic Information
10.8.2 Cepheid Point-of-care Molecular Diagnostic Solution Product Overview
10.8.3 Cepheid Point-of-care Molecular Diagnostic Solution Product Market Performance
10.8.4 Cepheid Business Overview
10.8.5 Cepheid Recent Developments
10.9 Inc.
10.9.1 Inc. Point-of-care Molecular Diagnostic Solution Basic Information
10.9.2 Inc. Point-of-care Molecular Diagnostic Solution Product Overview
10.9.3 Inc. Point-of-care Molecular Diagnostic Solution Product Market Performance
10.9.4 Inc. Business Overview
10.9.5 Inc. Recent Developments
10.10 Danaher Corporation
10.10.1 Danaher Corporation Point-of-care Molecular Diagnostic Solution Basic Information
10.10.2 Danaher Corporation Point-of-care Molecular Diagnostic Solution Product Overview
10.10.3 Danaher Corporation Point-of-care Molecular Diagnostic Solution Product Market Performance
10.10.4 Danaher Corporation Business Overview
10.10.5 Danaher Corporation Recent Developments
10.11 Johnson and Johnson
10.11.1 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Basic Information
10.11.2 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product Overview
10.11.3 Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product Market Performance
10.11.4 Johnson and Johnson Business Overview
10.11.5 Johnson and Johnson Recent Developments
10.12 Bayer Healthcare
10.12.1 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Basic Information
10.12.2 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product Overview
10.12.3 Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product Market Performance
10.12.4 Bayer Healthcare Business Overview
10.12.5 Bayer Healthcare Recent Developments
11 Point-of-care Molecular Diagnostic Solution Market Forecast by Region
11.1 Global Point-of-care Molecular Diagnostic Solution Market Size Forecast
11.2 Global Point-of-care Molecular Diagnostic Solution Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Point-of-care Molecular Diagnostic Solution Market Size Forecast by Country
11.2.3 Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size Forecast by Region
11.2.4 South America Point-of-care Molecular Diagnostic Solution Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Point-of-care Molecular Diagnostic Solution by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Point-of-care Molecular Diagnostic Solution Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Point-of-care Molecular Diagnostic Solution by Type (2025-2032)
12.1.2 Global Point-of-care Molecular Diagnostic Solution Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Point-of-care Molecular Diagnostic Solution by Type (2025-2032)
12.2 Global Point-of-care Molecular Diagnostic Solution Market Forecast by Application (2025-2032)
12.2.1 Global Point-of-care Molecular Diagnostic Solution Sales (K Units) Forecast by Application
12.2.2 Global Point-of-care Molecular Diagnostic Solution Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Point-of-care Molecular Diagnostic Solution Market Size Comparison by Region (M USD)
Table 5. Global Point-of-care Molecular Diagnostic Solution Sales (K Units) by Manufacturers (2019-2025)
Table 6. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Point-of-care Molecular Diagnostic Solution Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Molecular Diagnostic Solution as of 2022)
Table 10. Global Market Point-of-care Molecular Diagnostic Solution Average Price (USD/Unit) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Point-of-care Molecular Diagnostic Solution Sales Sites and Area Served
Table 12. Manufacturers Point-of-care Molecular Diagnostic Solution Product Type
Table 13. Global Point-of-care Molecular Diagnostic Solution Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Point-of-care Molecular Diagnostic Solution
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Point-of-care Molecular Diagnostic Solution Market Challenges
Table 22. Global Point-of-care Molecular Diagnostic Solution Sales by Type (K Units)
Table 23. Global Point-of-care Molecular Diagnostic Solution Market Size by Type (M USD)
Table 24. Global Point-of-care Molecular Diagnostic Solution Sales (K Units) by Type (2019-2025)
Table 25. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Type (2019-2025)
Table 26. Global Point-of-care Molecular Diagnostic Solution Market Size (M USD) by Type (2019-2025)
Table 27. Global Point-of-care Molecular Diagnostic Solution Market Size Share by Type (2019-2025)
Table 28. Global Point-of-care Molecular Diagnostic Solution Price (USD/Unit) by Type (2019-2025)
Table 29. Global Point-of-care Molecular Diagnostic Solution Sales (K Units) by Application
Table 30. Global Point-of-care Molecular Diagnostic Solution Market Size by Application
Table 31. Global Point-of-care Molecular Diagnostic Solution Sales by Application (2019-2025) & (K Units)
Table 32. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Application (2019-2025)
Table 33. Global Point-of-care Molecular Diagnostic Solution Sales by Application (2019-2025) & (M USD)
Table 34. Global Point-of-care Molecular Diagnostic Solution Market Share by Application (2019-2025)
Table 35. Global Point-of-care Molecular Diagnostic Solution Sales Growth Rate by Application (2019-2025)
Table 36. Global Point-of-care Molecular Diagnostic Solution Sales by Region (2019-2025) & (K Units)
Table 37. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Region (2019-2025)
Table 38. North America Point-of-care Molecular Diagnostic Solution Sales by Country (2019-2025) & (K Units)
Table 39. Europe Point-of-care Molecular Diagnostic Solution Sales by Country (2019-2025) & (K Units)
Table 40. Asia Pacific Point-of-care Molecular Diagnostic Solution Sales by Region (2019-2025) & (K Units)
Table 41. South America Point-of-care Molecular Diagnostic Solution Sales by Country (2019-2025) & (K Units)
Table 42. Middle East and Africa Point-of-care Molecular Diagnostic Solution Sales by Region (2019-2025) & (K Units)
Table 43. Global Point-of-care Molecular Diagnostic Solution Production (K Units) by Region (2019-2025)
Table 44. Global Point-of-care Molecular Diagnostic Solution Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Point-of-care Molecular Diagnostic Solution Revenue Market Share by Region (2019-2025)
Table 46. Global Point-of-care Molecular Diagnostic Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 47. North America Point-of-care Molecular Diagnostic Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 48. Europe Point-of-care Molecular Diagnostic Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 49. Japan Point-of-care Molecular Diagnostic Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 50. China Point-of-care Molecular Diagnostic Solution Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2025)
Table 51. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Basic Information
Table 52. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Product Overview
Table 53. Abbott Laboratories Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 54. Abbott Laboratories Business Overview
Table 55. Abbott Laboratories Point-of-care Molecular Diagnostic Solution SWOT Analysis
Table 56. Abbott Laboratories Recent Developments
Table 57. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Basic Information
Table 58. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Product Overview
Table 59. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 60. F. Hoffmann-La Roche AG Business Overview
Table 61. F. Hoffmann-La Roche AG Point-of-care Molecular Diagnostic Solution SWOT Analysis
Table 62. F. Hoffmann-La Roche AG Recent Developments
Table 63. Becton Point-of-care Molecular Diagnostic Solution Basic Information
Table 64. Becton Point-of-care Molecular Diagnostic Solution Product Overview
Table 65. Becton Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 66. Becton Point-of-care Molecular Diagnostic Solution SWOT Analysis
Table 67. Becton Business Overview
Table 68. Becton Recent Developments
Table 69. Dickinson and Company Point-of-care Molecular Diagnostic Solution Basic Information
Table 70. Dickinson and Company Point-of-care Molecular Diagnostic Solution Product Overview
Table 71. Dickinson and Company Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 72. Dickinson and Company Business Overview
Table 73. Dickinson and Company Recent Developments
Table 74. BioMerieux Point-of-care Molecular Diagnostic Solution Basic Information
Table 75. BioMerieux Point-of-care Molecular Diagnostic Solution Product Overview
Table 76. BioMerieux Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 77. BioMerieux Business Overview
Table 78. BioMerieux Recent Developments
Table 79. Bio-Rad Laboratories Point-of-care Molecular Diagnostic Solution Basic Information
Table 80. Bio-Rad Laboratories Point-of-care Molecular Diagnostic Solution Product Overview
Table 81. Bio-Rad Laboratories Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 82. Bio-Rad Laboratories Business Overview
Table 83. Bio-Rad Laboratories Recent Developments
Table 84. Inc. Point-of-care Molecular Diagnostic Solution Basic Information
Table 85. Inc. Point-of-care Molecular Diagnostic Solution Product Overview
Table 86. Inc. Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 87. Inc. Business Overview
Table 88. Inc. Recent Developments
Table 89. Cepheid Point-of-care Molecular Diagnostic Solution Basic Information
Table 90. Cepheid Point-of-care Molecular Diagnostic Solution Product Overview
Table 91. Cepheid Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 92. Cepheid Business Overview
Table 93. Cepheid Recent Developments
Table 94. Inc. Point-of-care Molecular Diagnostic Solution Basic Information
Table 95. Inc. Point-of-care Molecular Diagnostic Solution Product Overview
Table 96. Inc. Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 97. Inc. Business Overview
Table 98. Inc. Recent Developments
Table 99. Danaher Corporation Point-of-care Molecular Diagnostic Solution Basic Information
Table 100. Danaher Corporation Point-of-care Molecular Diagnostic Solution Product Overview
Table 101. Danaher Corporation Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 102. Danaher Corporation Business Overview
Table 103. Danaher Corporation Recent Developments
Table 104. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Basic Information
Table 105. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Product Overview
Table 106. Johnson and Johnson Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 107. Johnson and Johnson Business Overview
Table 108. Johnson and Johnson Recent Developments
Table 109. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Basic Information
Table 110. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Product Overview
Table 111. Bayer Healthcare Point-of-care Molecular Diagnostic Solution Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2019-2025)
Table 112. Bayer Healthcare Business Overview
Table 113. Bayer Healthcare Recent Developments
Table 114. Global Point-of-care Molecular Diagnostic Solution Sales Forecast by Region (2025-2032) & (K Units)
Table 115. Global Point-of-care Molecular Diagnostic Solution Market Size Forecast by Region (2025-2032) & (M USD)
Table 116. North America Point-of-care Molecular Diagnostic Solution Sales Forecast by Country (2025-2032) & (K Units)
Table 117. North America Point-of-care Molecular Diagnostic Solution Market Size Forecast by Country (2025-2032) & (M USD)
Table 118. Europe Point-of-care Molecular Diagnostic Solution Sales Forecast by Country (2025-2032) & (K Units)
Table 119. Europe Point-of-care Molecular Diagnostic Solution Market Size Forecast by Country (2025-2032) & (M USD)
Table 120. Asia Pacific Point-of-care Molecular Diagnostic Solution Sales Forecast by Region (2025-2032) & (K Units)
Table 121. Asia Pacific Point-of-care Molecular Diagnostic Solution Market Size Forecast by Region (2025-2032) & (M USD)
Table 122. South America Point-of-care Molecular Diagnostic Solution Sales Forecast by Country (2025-2032) & (K Units)
Table 123. South America Point-of-care Molecular Diagnostic Solution Market Size Forecast by Country (2025-2032) & (M USD)
Table 124. Middle East and Africa Point-of-care Molecular Diagnostic Solution Consumption Forecast by Country (2025-2032) & (Units)
Table 125. Middle East and Africa Point-of-care Molecular Diagnostic Solution Market Size Forecast by Country (2025-2032) & (M USD)
Table 126. Global Point-of-care Molecular Diagnostic Solution Sales Forecast by Type (2025-2032) & (K Units)
Table 127. Global Point-of-care Molecular Diagnostic Solution Market Size Forecast by Type (2025-2032) & (M USD)
Table 128. Global Point-of-care Molecular Diagnostic Solution Price Forecast by Type (2025-2032) & (USD/Unit)
Table 129. Global Point-of-care Molecular Diagnostic Solution Sales (K Units) Forecast by Application (2025-2032)
Table 130. Global Point-of-care Molecular Diagnostic Solution Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Point-of-care Molecular Diagnostic Solution
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Point-of-care Molecular Diagnostic Solution Market Size (M USD), 2019-2032
Figure 5. Global Point-of-care Molecular Diagnostic Solution Market Size (M USD) (2019-2032)
Figure 6. Global Point-of-care Molecular Diagnostic Solution Sales (K Units) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Point-of-care Molecular Diagnostic Solution Market Size by Country (M USD)
Figure 11. Point-of-care Molecular Diagnostic Solution Sales Share by Manufacturers in 2023
Figure 12. Global Point-of-care Molecular Diagnostic Solution Revenue Share by Manufacturers in 2023
Figure 13. Point-of-care Molecular Diagnostic Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Point-of-care Molecular Diagnostic Solution Average Price (USD/Unit) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Point-of-care Molecular Diagnostic Solution Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Point-of-care Molecular Diagnostic Solution Market Share by Type
Figure 18. Sales Market Share of Point-of-care Molecular Diagnostic Solution by Type (2019-2025)
Figure 19. Sales Market Share of Point-of-care Molecular Diagnostic Solution by Type in 2023
Figure 20. Market Size Share of Point-of-care Molecular Diagnostic Solution by Type (2019-2025)
Figure 21. Market Size Market Share of Point-of-care Molecular Diagnostic Solution by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Point-of-care Molecular Diagnostic Solution Market Share by Application
Figure 24. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Application (2019-2025)
Figure 25. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Application in 2023
Figure 26. Global Point-of-care Molecular Diagnostic Solution Market Share by Application (2019-2025)
Figure 27. Global Point-of-care Molecular Diagnostic Solution Market Share by Application in 2023
Figure 28. Global Point-of-care Molecular Diagnostic Solution Sales Growth Rate by Application (2019-2025)
Figure 29. Global Point-of-care Molecular Diagnostic Solution Sales Market Share by Region (2019-2025)
Figure 30. North America Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 31. North America Point-of-care Molecular Diagnostic Solution Sales Market Share by Country in 2023
Figure 32. U.S. Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 33. Canada Point-of-care Molecular Diagnostic Solution Sales (K Units) and Growth Rate (2019-2025)
Figure 34. Mexico Point-of-care Molecular Diagnostic Solution Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 36. Europe Point-of-care Molecular Diagnostic Solution Sales Market Share by Country in 2023
Figure 37. Germany Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 38. France Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 39. U.K. Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 40. Italy Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 41. Russia Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 42. Asia Pacific Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Point-of-care Molecular Diagnostic Solution Sales Market Share by Region in 2023
Figure 44. China Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 45. Japan Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 46. South Korea Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 47. India Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 48. Southeast Asia Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 49. South America Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (K Units)
Figure 50. South America Point-of-care Molecular Diagnostic Solution Sales Market Share by Country in 2023
Figure 51. Brazil Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 52. Argentina Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 53. Columbia Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 54. Middle East and Africa Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Point-of-care Molecular Diagnostic Solution Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 57. UAE Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 58. Egypt Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 59. Nigeria Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 60. South Africa Point-of-care Molecular Diagnostic Solution Sales and Growth Rate (2019-2025) & (K Units)
Figure 61. Global Point-of-care Molecular Diagnostic Solution Production Market Share by Region (2019-2025)
Figure 62. North America Point-of-care Molecular Diagnostic Solution Production (K Units) Growth Rate (2019-2025)
Figure 63. Europe Point-of-care Molecular Diagnostic Solution Production (K Units) Growth Rate (2019-2025)
Figure 64. Japan Point-of-care Molecular Diagnostic Solution Production (K Units) Growth Rate (2019-2025)
Figure 65. China Point-of-care Molecular Diagnostic Solution Production (K Units) Growth Rate (2019-2025)
Figure 66. Global Point-of-care Molecular Diagnostic Solution Sales Forecast by Volume (2019-2032) & (K Units)
Figure 67. Global Point-of-care Molecular Diagnostic Solution Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Point-of-care Molecular Diagnostic Solution Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Point-of-care Molecular Diagnostic Solution Market Share Forecast by Type (2025-2032)
Figure 70. Global Point-of-care Molecular Diagnostic Solution Sales Forecast by Application (2025-2032)
Figure 71. Global Point-of-care Molecular Diagnostic Solution Market Share Forecast by Application (2025-2032)
